Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 365, P. 833 - 847
Published: Dec. 16, 2023
Language: Английский
Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 365, P. 833 - 847
Published: Dec. 16, 2023
Language: Английский
Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 14(6), P. 2786 - 2789
Published: March 20, 2024
The current status of clinical trials utilizing nanoparticle drug delivery system (NDDS) for brain tumors was summarized.Image 1.
Language: Английский
Citations
3Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 371, P. 216 - 236
Published: May 31, 2024
Nanoparticles have a great potential to significantly improve the delivery of therapeutics brain and may also be equipped with properties investigate function. The brain, being highly complex organ shielded by selective barriers, requires its own specialized detection system. However, significant hurdle achieve these goals is still identification individual nanoparticles within sufficient cellular, subcellular, temporal resolution. This review aims provide comprehensive summary current knowledge on systems for tracking across blood-brain barrier brain. We discuss commonly employed in vivo ex nanoparticle quantification methods, as well various imaging modalities able detect Advantages weaknesses biological factors that must considered when interpreting results obtained through nanotechnologies are summarized. Finally, we critically evaluate prevailing limitations existing technologies explore solutions.
Language: Английский
Citations
3Journal of Materials Chemistry B, Journal Year: 2022, Volume and Issue: 10(37), P. 7384 - 7396
Published: Jan. 1, 2022
This review comprehensively covers the extraction, characterization, functionalization and biomedical applications of bacterial outer membrane vesicles (OMVs).
Language: Английский
Citations
14Asian Journal of Pharmaceutical Sciences, Journal Year: 2023, Volume and Issue: 18(4), P. 100827 - 100827
Published: July 1, 2023
Nano-targeted delivery systems have been widely used for breast tumor drug delivery. Estrogen receptors are considered to be significant target due their overexpression in a variety of cells. However, targeted ligands impact on the safety and effectiveness active systems, limiting clinical transformation nanoparticles. Phytoestrogens shown good biosafety characteristics some affinity with estrogen receptor. In present study, molecular docking was select tanshinone IIA (Tan IIA) among phytoestrogens as ligand nanodelivery modifications. Modified Tan (Tan-NH2) showed profile demonstrated tumor-targeting, anti-tumor metastasis effects. Moreover, utilized Dox-loaded mesoporous silica nanoparticles via chemical modification generate nanocomposite Tan-Dox-MSN. Tan-Dox-MSN had uniform particle size, dispersibility high loading capacity. Validation experiments vivo vitro that it also better targeting ability, effect lower toxicity normal organs. These results supported idea receptor could improve therapeutic efficacy nano-targeted tumors.
Language: Английский
Citations
5Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 365, P. 833 - 847
Published: Dec. 16, 2023
Language: Английский
Citations
4